Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents
Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents
Active, not recruiting · NCT04739800 · Registry updated 2026-10-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents | fallopian tube mucinous adenocarcinoma, ovarian seromucinous carcinoma | Active, not recruiting | Phase 2 | 2026-10-01 | NCT04739800 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
| NRG Oncology | 93 |
391 results · Page 1 of 16
Research sites
Swipe the table sideways for more columns.